These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22709571)

  • 21. Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine.
    Castellsagué J; Gel B; Fernández-Rodríguez J; Llatjós R; Blanco I; Benavente Y; Pérez-Sidelnikova D; García-Del Muro J; Viñals JM; Vidal A; Valdés-Mas R; Terribas E; López-Doriga A; Pujana MA; Capellá G; Puente XS; Serra E; Villanueva A; Lázaro C
    EMBO Mol Med; 2015 May; 7(5):608-27. PubMed ID: 25810463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary human non-small cell lung and pancreatic tumorgraft models--utility and applications in drug discovery and tumor biology.
    Calles A; Rubio-Viqueira B; Hidalgo M
    Curr Protoc Pharmacol; 2013 Jun; Chapter 14():Unit 14.26. PubMed ID: 23744711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemo brain or tumor brain - that is the question: the presence of extracranial tumors profoundly affects molecular processes in the prefrontal cortex of TumorGraft mice.
    Kovalchuk A; Ilnytskyy Y; Rodriguez-Juarez R; Shpyleva S; Melnyk S; Pogribny I; Katz A; Sidransky D; Kovalchuk O; Kolb B
    Aging (Albany NY); 2017 Jul; 9(7):1660-1676. PubMed ID: 28758896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models.
    Garcia PL; Miller AL; Kreitzburg KM; Council LN; Gamblin TL; Christein JD; Heslin MJ; Arnoletti JP; Richardson JH; Chen D; Hanna CA; Cramer SL; Yang ES; Qi J; Bradner JE; Yoon KJ
    Oncogene; 2016 Feb; 35(7):833-45. PubMed ID: 25961927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
    Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
    J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-Derived Bladder Cancer Xenografts.
    Bernardo C; Santos LL
    Methods Mol Biol; 2018; 1655():169-175. PubMed ID: 28889386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic profiling of patient-derived colon cancer xenograft models.
    Lee WS; Kim HY; Seok JY; Jang HH; Park YH; Kim SY; Shin DB; Hong S
    Medicine (Baltimore); 2014 Dec; 93(28):e298. PubMed ID: 25526474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.
    Bergamaschi A; Hjortland GO; Triulzi T; Sørlie T; Johnsen H; Ree AH; Russnes HG; Tronnes S; Maelandsmo GM; Fodstad O; Borresen-Dale AL; Engebraaten O
    Mol Oncol; 2009 Dec; 3(5-6):469-82. PubMed ID: 19713161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer.
    Zhu M; Jia N; Nie Y; Chen J; Jiang Y; Lv T; Li Y; Yao L; Feng W
    Int J Gynecol Cancer; 2018 Nov; 28(9):1812-1820. PubMed ID: 30358704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-Derived Xenograft Models of Colorectal Cancer: Procedures for Engraftment and Propagation.
    Burgenske DM; Monsma DJ; MacKeigan JP
    Methods Mol Biol; 2018; 1765():307-314. PubMed ID: 29589317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
    Monsma DJ; Cherba DM; Richardson PJ; Vance S; Rangarajan S; Dylewski D; Eugster E; Scott SB; Beuschel NL; Davidson PJ; Axtell R; Mitchell D; Lester EP; Junewick JJ; Webb CP; Monks NR
    Pediatr Blood Cancer; 2014 Sep; 61(9):1570-7. PubMed ID: 24687871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
    Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
    Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.
    Zhang T; Zhang L; Fan S; Zhang M; Fu H; Liu Y; Yin X; Chen H; Xie L; Zhang J; Gavine PR; Gu Y; Ni X; Su X
    PLoS One; 2015; 10(7):e0134493. PubMed ID: 26217940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiling of patient-derived breast cancer xenografts.
    Reyal F; Guyader C; Decraene C; Lucchesi C; Auger N; Assayag F; De Plater L; Gentien D; Poupon MF; Cottu P; De Cremoux P; Gestraud P; Vincent-Salomon A; Fontaine JJ; Roman-Roman S; Delattre O; Decaudin D; Marangoni E
    Breast Cancer Res; 2012 Jan; 14(1):R11. PubMed ID: 22247967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification.
    Castven D; Becker D; Czauderna C; Wilhelm D; Andersen JB; Strand S; Hartmann M; Heilmann-Heimbach S; Roth W; Hartmann N; Straub BK; Mahn FL; Franck S; Pereira S; Haupts A; Vogel A; Wörns MA; Weinmann A; Heinrich S; Lang H; Thorgeirsson SS; Galle PR; Marquardt JU
    Int J Cancer; 2019 Jun; 144(11):2782-2794. PubMed ID: 30485423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements.
    Delitto D; Pham K; Vlada AC; Sarosi GA; Thomas RM; Behrns KE; Liu C; Hughes SJ; Wallet SM; Trevino JG
    Am J Pathol; 2015 May; 185(5):1297-303. PubMed ID: 25770474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
    Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
    J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.